140 related articles for article (PubMed ID: 15721498)
1. Long-term (> 8 weeks) home inotropic therapy as destination therapy in patients with advanced heart failure or as bridge to heart transplantation.
Jiménez J; Jara J; Bednar B; Bauerlein J; Mallon S
Int J Cardiol; 2005 Mar; 99(1):47-50. PubMed ID: 15721498
[No Abstract] [Full Text] [Related]
2. [Dobutamine therapy at home under the guidance of a nurse practitioner, either as a bridge to cardiac transplantation or as destination therapy in severe heart failure].
Brügemann J; de Jonge-Weber AT; Rienstra M; van den Broek SA; Zijlstra F; van Veldhuisen DJ
Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2460-5. PubMed ID: 18064867
[TBL] [Abstract][Full Text] [Related]
3. Home inotropic therapy in children.
Berg AM; Snell L; Mahle WT
J Heart Lung Transplant; 2007 May; 26(5):453-7. PubMed ID: 17449413
[TBL] [Abstract][Full Text] [Related]
4. Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart failure.
Price JF; Towbin JA; Dreyer WJ; Moffett BS; Kertesz NJ; Clunie SK; Denfield SW
J Card Fail; 2006 Mar; 12(2):139-43. PubMed ID: 16520263
[TBL] [Abstract][Full Text] [Related]
5. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
[TBL] [Abstract][Full Text] [Related]
6. [Infusion of inotropic agents at home in patients with severe heart failure: an important role for the nurse practitioner].
Ypenburg C; Verwey HF; van der Wall EE
Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2426-8. PubMed ID: 18064859
[TBL] [Abstract][Full Text] [Related]
7. Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy.
Stevenson LW
Circulation; 2003 Jul; 108(4):492-7. PubMed ID: 12885733
[No Abstract] [Full Text] [Related]
8. Comparison of survival by allocation to medical therapy, surgery, or heart transplantation for ischemic advanced heart failure.
Lim E; Ali Z; Ali A; Motalleb-Zadeh R; Jackson C; Ong SL; Halstead J; Sharples L; Parameshwar J; Wallwork J; Large SR
J Heart Lung Transplant; 2005 Aug; 24(8):983-9. PubMed ID: 16102430
[TBL] [Abstract][Full Text] [Related]
9. Inotropic therapy in the home care setting: criteria, management, and implications.
Mayes J; Carter C; Adams JE
J Intraven Nurs; 1995; 18(6):301-6. PubMed ID: 8699289
[TBL] [Abstract][Full Text] [Related]
10. Potential of medical treatment, device therapy, and conventional surgery in patients referred for heart transplantation.
Grigioni F; Potena L; Russo A; Boriani G; Masetti M; Magnani G; Coccolo F; Fallani F; Branzi A
J Card Surg; 2007; 22(5):456-8. PubMed ID: 17803592
[No Abstract] [Full Text] [Related]
11. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
[TBL] [Abstract][Full Text] [Related]
12. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
[TBL] [Abstract][Full Text] [Related]
13. Oral heart failure medications: an update for home health clinicians.
Cheek DJ; Sherrod MM; Graulty R; Hawkins J
Home Healthc Nurse; 2008; 26(10):600-11; quiz 612-3. PubMed ID: 19001915
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation.
Zemljic G; Bunc M; Yazdanbakhsh AP; Vrtovec B
J Card Fail; 2007 Aug; 13(6):417-21. PubMed ID: 17675054
[TBL] [Abstract][Full Text] [Related]
15. The use of continuous milrinone therapy as bridge to transplant is safe in patients with short waiting times.
Assad-Kottner C; Chen D; Jahanyar J; Cordova F; Summers N; Loebe M; Merla R; Youker K; Torre-Amione G
J Card Fail; 2008 Dec; 14(10):839-43. PubMed ID: 19041047
[TBL] [Abstract][Full Text] [Related]
16. [Management of advanced chronic heart failure].
Oliva F; Macera F; Verde A; Frigerio M
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):112S-117S. PubMed ID: 19195318
[TBL] [Abstract][Full Text] [Related]
17. Clinical use of inotropic therapy for heart failure: looking backward or forward? Part I: inotropic infusions during hospitalization.
Stevenson LW
Circulation; 2003 Jul; 108(3):367-72. PubMed ID: 12876135
[No Abstract] [Full Text] [Related]
18. Cardiac transplantation: recipient selection criteria and pathophysiology and management of advanced heart failure.
Algeo SS
Contemp Anesth Pract; 1987; 10():47-72. PubMed ID: 3555999
[No Abstract] [Full Text] [Related]
19. Predictors of clinical outcome in advanced heart failure patients on continuous intravenous milrinone therapy.
Bhat G
ASAIO J; 2006; 52(6):677-81. PubMed ID: 17117058
[TBL] [Abstract][Full Text] [Related]
20. Advanced heart failure: a call to action.
Russell SD; Miller LW; Pagani FD
Congest Heart Fail; 2008; 14(6):316-21. PubMed ID: 19076855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
